PATENT CLAIM ANALYSIS

Application Number: 15750583
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-05
Patent Classification: ["514", "063000"]

Abstract:
The present invention provides a compound of general formula (I) (wherein, R 1 , X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.

Claim (Index 6):
The compound according to  claim 1 , of general formula (III): wherein,\n R 1  represents a hydrogen atom, protecting group, optionally substituted C 1 -C 6  alkyl group, optionally substituted C 2 -C 6  alkenyl group, optionally substituted C 3 -C 8  cycloalkyl group, optionally substituted C 1 -C 6  alkoxy-C 1 -C 6  alkyl group, \u2014CONR 11 R 12 , optionally substituted heterocyclyl group, optionally substituted heterocyclyl-C 1 -C 6  alkyl group, optionally substituted aryl group or optionally substituted C 7 -C 16  aralkyl group, and \n R 2  represents a hydrogen atom, halogen atom, optionally substituted C 1 -C 6  alkyl group, optionally substituted C 3 -C 5  cycloalkyl group, optionally substituted C 1 -C 6  alkoxy group or cyano group, and \n p and q, independently of each other, represent a natural number of 1 to 3, provided that the sum of p and q is a natural number of 2 to 4, \n wherein, the term \u201csubstituted\u201d refers to being substituted with at least one substituent selected from the group consisting of a deuterium atom, halogen atom, C 1 -C 6  alkyl group, C 1 -C 6  alkoxy group, C 1 -C 6  alkoxy-C 1 -C 6  alkyl group, R 13 O\u2014C 1 -C 6  alkyl group, halo-C 1 -C 6  alkyl group, C 7 -C 16  aralkyl group, C 1 -C 7  acyl group, cyano group, oxo group, \u2014CONR 11 R 12 , \u2014OR 13 , \u2014COOR 14 , \u2014NR 15 R 16  and \u2014S(O) n R 17 , \n R 11  and R 12  independently represent a hydrogen atom or C 1 -C 6  alkyl group, R 13  represents a hydrogen atom, C 1 -C 7  acyl group or protecting group, R 14  represents a hydrogen atom or C 1 -C 6  alkyl group, R 15  and R 16  independently represent a hydrogen atom, C 1 -C 6  alkyl group, C 7 -C 16  aralkyl group, C 1 -C 7  acyl group, \u2014COOR 14  or \u2014S(O) n R 17 , R 17  represents a C 1 -C 6  alkyl group, and n represents 0, 1 or 2; \n or a pharmacologically acceptable salt thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.32432
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13809115', '13234514', '12604691', '11508322', '13503083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8086077839365051
- 35 USC 102 Novelty (BERT): 0.5367997838660883
- Combined Prediction Score: 0.7814269839294635
- Mean Citation Score: 349.460232
- Max Citation Score: 362.0457
- Similarity Product: 261.44384575901626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test